Monthly Archives: July 2010

French Political Leader Visits Sanford-Burnham

Gérard Collomb, Senator and Mayor of the city of Lyon in France, along with other representatives of Lyon and some of their business collaborators, paid a visit to the Institute’s La Jolla campus yesterday, where they met with Dr. Paul

Posted in Events News, French BioBeach Events

Celgene to buy Abraxis for $2.9B in biotech deal

By MARLEY SEAMAN AP Health Writer NEW YORK (AP) – Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock. Celgene Corp.

Posted in Latests News and Alerts

Senator Mayor of Lyon, Mr Gérard Collomb to visit San Diego

It is our pleasure to inform you that Gerard Collomb, Senator of the Rhones-Alpes region and Mayor of the city of Lyon (France), will be in San Diego on July 22nd, 2010, along with his close collaborators and main representatives

Posted in Events News, French BioBeach Events

New call for proposals planned to be published on 20 July 2010 – ERC Starting Grants

This grant competition is targeted at early-career research leaders, of any age, with 2-12 years of experience after their PhD. The researchers can be of any nationality as long as they are working, or moving to work, in Europe. The

Posted in Latests News and Alerts

Office of Science Announces the Early Career Research Program for FY 2011

Source: http://www.science.doe.gov/News_Information/News_Room/2010/July%201_EarlyCareer.html WASHINGTON, DC – The U.S. Department of Energy (DOE) announced today it is accepting proposals for the second year of the DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in

Posted in Latests News and Alerts

Arena Pharma, Eisai to Sell Obesity Drug

source: http://online.wsj.com/article/SB10001424052748703571704575340880052218588.html NEW YORK—Arena Pharmaceuticals Inc. signed a deal for Japanese drug maker Eisai Co. to sell experimental weight-loss drug lorcaserin in the U.S., if it is approved by the Food and Drug Administration. The deal, the value of which

Posted in Latests News and Alerts

“Cord Blood and Adult Stem Cells for biotechnology and regenerative medicine”

Title: “Cord Blood and Adult Stem Cells for biotechnology and regenerative medicine”Location: ARTERRA at the DEL MAR MARRIOTT 11966 El Camino Real Del Mar, CA CA 92130Link out: Click hereDescription: What? We are glad to announce that we will be

Tagged with: , , , ,
Posted in French BioBeach Events, Members Only

SD News: Sanofi-aventis To Acquire TargeGen, Inc.

Source: http://www.targegen.com/news063010.htm San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN; NYSE:

Posted in Events News, Latests News and Alerts, Members Only, Other Events, Press Releases
  • Newsletter
  • Facebook
  • LinkedIn
  • Twitter
  • Picasa
  • Flickr
  • YouTube